NCT03618745 is a clinical trial of CT brain in Impaired Consciousness, sponsored by Assiut University.

Who is sponsoring NCT03618745?

NCT03618745 is sponsored by Assiut University.

What drugs are being tested in NCT03618745?

Interventions in NCT03618745: CT brain.

What condition does NCT03618745 study?

NCT03618745 studies Impaired Consciousness.

Is NCT03618745 still recruiting?

NCT03618745 is currently status unknown. Last updated 7 August 2018.

Last reviewed 2018-08-07 · How we verify

NCT03618745

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcome Predictors of Non Traumatic Coma in Children

Status unknown Last updated 7 August 2018

What this trial tests

trial testing CT brain in Impaired Consciousness in 50 participants. Status unknown.

Timeline

1 September 2018

Primary endpoint
1 September 2019

1 December 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 September 2018
Primary completion	1 September 2019
Estimated completion	1 December 2019

Drugs / interventions tested

CT brain

Conditions studied

Impaired Consciousness — all drugs for Impaired Consciousness →

Sponsor

Assiut University

Who can join

Adults 2 Months to 18, any sex, with Impaired Consciousness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To catch the high risk comatosed child to improve service and direct the limited resources to those children in countries with limited resources .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Impaired Consciousness

Currently open trials in the same condition.

NCT06958341 — Neuroimmunology Registry and Biobank · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03618745 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 7 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03618745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing